This inventor holds 1 USPTO granted patent. Top assignee: Chinese Academy of Sciences. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2010
Title: Xiangdong Qin – Innovator in Antiviral Pharmaceutical Research
Introduction
Xiangdong Qin, an accomplished inventor based in Kunming, China, has made significant strides in the field of antiviral research. His work focuses on developing innovative compounds that could combat serious health threats, such as infections caused by the human immunodeficiency virus (HIV).
Latest Patents
One of Xiangdong Qin's notable contributions to the pharmaceutical industry is his single patent, titled "Concentricolide and its derivatives, process for preparing them, pharmaceutical composition comprising the same and its use." This invention highlights the potential of concentricolide and its derivatives in forming effective treatments for HIV, marking an important step forward in the fight against viral infections.
Career Highlights
Xiangdong Qin is affiliated with the Chinese Academy of Sciences, a leading research institution in China known for its innovative contributions to various scientific fields. His dedication to research and development has positioned him as a key figure in pharmaceutical innovation, especially concerning antiviral solutions.
Collaborations
Throughout his career, Xiangdong Qin has collaborated with esteemed colleagues such as Jikai Liu and Yongtang Zheng. These collaborations have fostered a dynamic research environment that encourages knowledge sharing and innovation, resulting in remarkable advancements in their respective areas of expertise.
Conclusion
Xiangdong Qin's dedication to the development of effective pharmaceutical solutions showcases the vital role of inventors in advancing healthcare. His contributions not only reflect personal achievement but also highlight the importance of collaboration in scientific research within esteemed institutions like the Chinese Academy of Sciences.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile